Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$0.42 - $0.72 $490,878 - $841,505
1,168,758 Added 7210.99%
1,184,966 $746,000
Q3 2023

Nov 09, 2023

SELL
$0.6 - $1.53 $29,091 - $74,183
-48,486 Reduced 74.95%
16,208 $9,000
Q2 2023

Aug 11, 2023

SELL
$1.05 - $1.63 $447 - $694
-426 Reduced 0.65%
64,694 $73,000
Q1 2023

May 12, 2023

SELL
$1.2 - $2.73 $510,816 - $1.16 Million
-425,680 Reduced 86.73%
65,120 $87,000
Q4 2022

Feb 08, 2023

BUY
$1.71 - $3.61 $132,937 - $280,645
77,741 Added 18.82%
490,800 $912,000
Q3 2022

Nov 10, 2022

BUY
$1.9 - $8.63 $612,252 - $2.78 Million
322,238 Added 354.81%
413,059 $1.02 Million
Q2 2022

Aug 10, 2022

SELL
$2.13 - $9.01 $373,682 - $1.58 Million
-175,438 Reduced 65.89%
90,821 $222,000
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $1.1 Million - $2.74 Million
-175,587 Reduced 39.74%
266,259 $2.12 Million
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $1.91 Million - $3.72 Million
129,689 Added 41.55%
441,846 $6.75 Million
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $2.44 Million - $3.37 Million
100,331 Added 47.36%
312,157 $8.88 Million
Q2 2021

Aug 13, 2021

SELL
$26.09 - $40.4 $708,995 - $1.1 Million
-27,175 Reduced 11.37%
211,826 $7.15 Million
Q1 2021

May 12, 2021

SELL
$33.06 - $56.93 $921,911 - $1.59 Million
-27,886 Reduced 10.45%
239,001 $9.13 Million
Q4 2020

Feb 11, 2021

BUY
$39.09 - $57.4 $3.01 Million - $4.43 Million
77,107 Added 40.63%
266,887 $11.2 Million
Q3 2020

Nov 12, 2020

BUY
$28.43 - $44.67 $531,555 - $835,194
18,697 Added 10.93%
189,780 $8.23 Million
Q2 2020

Jul 31, 2020

SELL
$11.71 - $30.29 $550,744 - $1.42 Million
-47,032 Reduced 21.56%
171,083 $5.18 Million
Q1 2020

May 01, 2020

BUY
$7.64 - $27.5 $1.03 Million - $3.7 Million
134,581 Added 161.11%
218,115 $2.98 Million
Q4 2019

Feb 14, 2020

SELL
$15.02 - $20.57 $4.59 Million - $6.28 Million
-305,260 Reduced 78.51%
83,534 $1.35 Million
Q3 2019

Nov 14, 2019

BUY
$18.85 - $27.5 $2.37 Million - $3.46 Million
125,677 Added 47.76%
388,794 $7.49 Million
Q2 2019

Aug 14, 2019

BUY
$17.37 - $26.27 $2.84 Million - $4.29 Million
163,325 Added 163.67%
263,117 $6.18 Million
Q1 2019

May 14, 2019

SELL
$10.65 - $25.75 $2.25 Million - $5.44 Million
-211,395 Reduced 67.93%
99,792 $2.34 Million
Q4 2018

Feb 14, 2019

BUY
$9.26 - $16.38 $1.16 Million - $2.06 Million
125,526 Added 67.61%
311,187 $3.44 Million
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $1.09 Million - $2.64 Million
144,374 Added 349.68%
185,661 $3.11 Million
Q2 2018

Aug 14, 2018

BUY
$4.87 - $8.42 $69,519 - $120,195
14,275 Added 52.85%
41,287 $304,000
Q1 2018

May 15, 2018

BUY
$4.69 - $10.05 $22,357 - $47,908
4,767 Added 21.43%
27,012 $127,000
Q4 2017

Feb 14, 2018

BUY
$7.86 - $9.99 $23,304 - $29,620
2,965 Added 15.38%
22,245 $202,000
Q3 2017

Nov 14, 2017

BUY
$8.89 - $10.4 $25,834 - $30,222
2,906 Added 17.75%
19,280 $180,000
Q2 2017

Aug 14, 2017

BUY
N/A
10,736 Added 190.42%
16,374 $157,000
Q1 2017

Nov 14, 2017

BUY
N/A
5,638
5,638 $63,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.